Skip to main content

Alka-Seltzer Plus Cold Formula Cherry Burst Effervescent Tablets and Alcohol/Food Interactions

There is 1 alcohol/food/lifestyle interaction with Alka-Seltzer Plus Cold Formula Cherry Burst Effervescent Tablets (aspirin / chlorpheniramine / phenylephrine).

Moderate

Chlorpheniramine Food

Moderate Food Interaction

Consumer information for this interaction is not currently available.

GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of CNS-active agents. Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.

MANAGEMENT: Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol. Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.

Switch to professional interaction data

Alka-Seltzer Plus Cold Formula Cherry Burst Effervescent Tablets drug interactions

There are 786 drug interactions with Alka-Seltzer Plus Cold Formula Cherry Burst Effervescent Tablets (aspirin / chlorpheniramine / phenylephrine).

Alka-Seltzer Plus Cold Formula Cherry Burst Effervescent Tablets disease interactions

There are 17 disease interactions with Alka-Seltzer Plus Cold Formula Cherry Burst Effervescent Tablets (aspirin / chlorpheniramine / phenylephrine) which include:

Report options

Loading...
QR code containing a link to this page

More about Alka-Seltzer Plus Cold Formula Cherry Burst Effervescent Tablets (aspirin / chlorpheniramine / phenylephrine)

Related treatment guides

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer